MedPath

The Role of TextRAd on Detection of Liver Metastasis in Rectal Cancer

Completed
Conditions
Rectal Cancer
Registration Number
NCT05398822
Lead Sponsor
East Suffolk and North Essex NHS Foundation Trust
Brief Summary

This is a retrospective analysis of all patients diagnosed with LARC who received NCRT and had MRI scans between 2003-2014 at East Suffolk and North Essex NHS Foundation Trust. Region of interest was drawn around the tumor or its location on T2 MRI images. Six texture parameters were systematically extracted from Textural histograms of post-treatment scans. These parameters were examined to determine their ability to predict local recurrence and distant metastases through Kaplan-Meier survival curves and log-rank tests.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
113
Inclusion Criteria
  • All subjects must have MRI post-Chemotherapy treatment to detect the response to Neoadjuvant treatment and compare it to pre-treatment scans to easily determine if there were a posttreatment liver metastasis.
  • Locally advanced rectal cancer (LARC) = MRI stage: T3/T4 and/or N1/N0.
Exclusion Criteria
  • Distant metastases.
  • Synchronous tumour.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Local recurrence of rectal cancer120 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

East Suffolk and North Essex NHS Foundation Trust

🇬🇧

Ipswich, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath